<DOC>
	<DOC>NCT01937390</DOC>
	<brief_summary>The objective of the study is to observe the effect of adherence to once-daily administered long-acting bronchodilators (long-acting ß2-agonists [LABAs] / long-acting muscarinic antagonists [LAMAs]) on patients health related quality of life (HR-QoL) and to assess the relation between symptoms improvement and adherence to Chronic Obstructive Pulmonary Disease (COPD) maintenance therapy</brief_summary>
	<brief_title>Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criteria: 1. Male or female, above 40 years of age 2. Patients clinically diagnosed of COPD with no history suggestive of asthma: 1. by scores &gt;=5 in the COPD Population Screener, 2. by a clinical diagnosis of COPD made by pulmonologists or internists, 3. by a Forced Expiratory Volume (FEV1)/ Forced Vital Capacity (FVC6) ratio of &lt;=0.70 and a FEV1 &lt;=80% of the predicted value as assessed by copd6 (Vitalograph, UK); 3. Maintenance treatmentnaïve COPD patients who have been prescribed once daily longacting bronchodilators (LABAs / LAMAs) for the first time at enrolment into the study 4. Patients who are able to provide signed informed consent 5. Patients who agree to be contacted for telephone/ SMS reminders via call center Exclusion criteria: 1. Patients with contraindications to the prescribed medication 2. Patients with any disorder that would prevent the patient from being able to complete questionnaires either verbally or by selfcompletion 3. Pregnant or lactating women or women of childbearing potential not using an acceptable method of contraception</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>